Betamethasone Dipropionate

   
Google
 
Web NewDrugInformation.com

Betamethasone Dipropionate


Drug - Betamethasone Dipropionate
The trade name of the product as shown on the labeling.

Dosage - OINTMENT; TOPICAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Betamethasone Dipropionate
Multiple ingredients are in alphabetical order.

Strength - EQ 0.05% BASE
The potency of the active ingredient(s), Betamethasone Dipropionate. May repeat for multiple part products.

Applicant - PHARMADERM
The firm name holding legal responsibility for Betamethasone Dipropionate. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 019140
The FDA assigned number to Betamethasone Dipropionate. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Betamethasone Dipropionate. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Sep 4, 1984
The date Betamethasone Dipropionate was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Betamethasone Dipropionate. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Betamethasone Dipropionate is in. Format is RX, OTC, DISCN.

Applicant Full Name - Pharmaderm Div Altana Inc
The full name of the firm holding legal responsibility for the new application of Betamethasone Dipropionate.

Betamethasone Dipropionate